Interestingly, Coco, an antagonist of TGF-β ligands, reactivated breast cancer cells in lung metastatic sites, but it was not associated with the promotion of bone or brain metastases [106], suggesting distinct implicated mechanisms in different target organs. This evidence concerns the gene TGFB1 and breast carcinoma.